Recount of FOURIER Information Finds Increased Mortality With Evolocumab
Readjudication of mortality information from the FOURIER trial suggests a better danger for cardiovascular dying with evolocumab (Repatha) amongst sufferers...
Readjudication of mortality information from the FOURIER trial suggests a better danger for cardiovascular dying with evolocumab (Repatha) amongst sufferers...